Tactile Systems Technology Inc.08.14.17
Tactile Systems Technology Inc. (Tactile Medical), a developer of medical devices for the treatment of chronic diseases at home, has appointed Cheryl Pegus, M.D., M.P.H., to the company’s Board of Directors, effective July 28.
“We are very pleased to have attracted a physician executive of the caliber of Dr. Pegus to our Board. Cheryl brings to us deep experience in health outcomes, analytics and population management, while also providing us her unique perspective gained from serving as chief medical officer for both a national payer and a major provider,” Tactile Board Chairman Peter H. Soderberg said. “Cheryl is the first director we have added since Tactile Medical went public just over a year ago, and her addition represents important progress in strengthening our board to further support Tactile Medical’s growth opportunities.”
Pegus is currently clinical professor of medicine and population health at NYU Langone Medical Center. She formerly served as the first chief medical officer of Walgreen Co. from 2010 to 2013, where she assisted in the expansion of its healthcare services, new product launches and data analytics. Prior to joining Walgreens, Pegus was the general manager and chief medical officer of SymCare Personalized Health Solutions Inc., a Johnson & Johnson startup company, and the national medical director/clinical product head for Aetna Inc.
Pegus currently serves as a director on the boards of Cogentix Medical Inc., Glytec LLC, and U.S. Acute Care Solutions. Within the medical academic community, she currently serves as a board member of the founder’s affiliate of the American Heart Association and as a board member and incoming chair of the Association of Black Cardiologists.
Tactile Medical develops and markets at-home therapy devices that treat lymphedema and chronic venous insufficiency. Its offering includes advanced, clinically-proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. The company is based in Minneapolis, Minn.
“We are very pleased to have attracted a physician executive of the caliber of Dr. Pegus to our Board. Cheryl brings to us deep experience in health outcomes, analytics and population management, while also providing us her unique perspective gained from serving as chief medical officer for both a national payer and a major provider,” Tactile Board Chairman Peter H. Soderberg said. “Cheryl is the first director we have added since Tactile Medical went public just over a year ago, and her addition represents important progress in strengthening our board to further support Tactile Medical’s growth opportunities.”
Pegus is currently clinical professor of medicine and population health at NYU Langone Medical Center. She formerly served as the first chief medical officer of Walgreen Co. from 2010 to 2013, where she assisted in the expansion of its healthcare services, new product launches and data analytics. Prior to joining Walgreens, Pegus was the general manager and chief medical officer of SymCare Personalized Health Solutions Inc., a Johnson & Johnson startup company, and the national medical director/clinical product head for Aetna Inc.
Pegus currently serves as a director on the boards of Cogentix Medical Inc., Glytec LLC, and U.S. Acute Care Solutions. Within the medical academic community, she currently serves as a board member of the founder’s affiliate of the American Heart Association and as a board member and incoming chair of the Association of Black Cardiologists.
Tactile Medical develops and markets at-home therapy devices that treat lymphedema and chronic venous insufficiency. Its offering includes advanced, clinically-proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. The company is based in Minneapolis, Minn.